Open AccessMale breast cancer after finasteride therapy for benign prostate hyperplasia
Author(s) -
Jui Ming Liu,
YiHsuan Chiang,
Lin Chen,
YungFeng Lo,
Chih Yuan Chou
Publication year - 2013
Publication title -
urological science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 8
eISSN - 1879-5234
pISSN - 1879-5226
DOI - 10.1016/j.urols.2012.06.001
Subject(s) - medicine , finasteride , tamoxifen , male breast cancer , urology , gynecomastia , prostate cancer , hyperplasia , breast cancer , prostate , cancer , gynecology , oncology
Finasteride has been used for the treatment of benign prostate hyperplasia (BPH) for years, but some side effects, including male breast cancer (MBC), have been reported. We report a case of breast cancer in a male patient who received finasteride therapy for BPH, and to our knowledge, our report is believed to be the first in Taiwan. The patient was a 59-year-old man who received finasteride therapy for BPH for 4 years. He found a palpable mass in his left breast 2 months prior to diagnosis. Ultrasound-guided core biopsy showed invasive ductal carcinoma. A simple mastectomy was performed followed by chemotherapy with tamoxifen